Clinical Trials Using Technetium Tc-99m Sestamibi

Clinical trials are research studies that involve people. The clinical trials on this list are studying Technetium Tc-99m Sestamibi. All trials on the list are supported by NCI.

NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.

Trials 1-4 of 4
  • Technetium Tc-99m Sestamibi SPECT / CT Imaging in Treating Patients with Kidney Cancer

    This phase I trial studies how well technetium Tc-99m sestamibi single-photon emission computed tomography (SPECT) / computed tomography (CT) imaging works in treating patients with kidney cancer. Diagnostic procedures, such as technetium Tc-99m sestamibi SPECT / CT, may help find and diagnose kidney cancer.
    Location: Johns Hopkins University / Sidney Kimmel Cancer Center, Baltimore, Maryland

  • DCE-MRI and MBI in Assessing Tumor Response to Chemotherapy in Patients with Triple Negative Breast Cancer

    This early phase I trial studies how well dynamic contrast enhanced molecular resonance imaging (DCE-MRI) and technetium-Tc99m sestamibi molecular breast imaging (MBI) work in assessing tumor response to chemotherapy in patients with triple negative breast cancer (TNBC) who are undergoing chemotherapy. Investigational imaging scans such as MBI and DCE-MRI may help researchers predict which patients may respond to treatment.
    Location: 6 locations

  • Technetium Tc-99m Sestamibi Molecular Breast Imaging in Predicting Tumor Response in Patients with Locoregional Invasive Breast Cancer Receiving Neoadjuvant Chemotherapy

    This clinical trial studies technetium Tc-99m sestamibi molecular breast imaging in predicting tumor response in patients with locoregional breast cancer that has spread from where it began in the breast to surrounding normal tissue who are receiving neoadjuvant chemotherapy. Comparing results of diagnostic procedures, such as technetium Tc-99m sestamibi molecular breast imaging, done before, during, and after chemotherapy may help doctors predict a patient's response to treatment and help plan the best treatment.
    Location: M D Anderson Cancer Center, Houston, Texas

  • SPECT / CT for the Characterization of Renal Masses

    This trial studies how well technetium Tc-99m sestamibi single-photon emission computed tomography / computed tomography (SPECT / CT) works on clinical decision making in patients with kidney tumors. Diagnostic procedures, such as technetium Tc-99m sestamibi SPECT / CT may be a less invasive way to check for kidney tumors.
    Location: UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California